Tsai-Yuan Hsieh
Overview
Explore the profile of Tsai-Yuan Hsieh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
1088
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang H, Zeng Y, Huang C, Chen C, Kuo H, Tseng K, et al.
J Formos Med Assoc
. 2025 Mar;
PMID: 40023754
Purpose: This study investigated whether Fibrosis-4 (FIB-4) score and its change can serve as predictors of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C (CHC) infection receiving direct-acting...
2.
Chen Y, Tsai P, Huang C, Chen C, Hung C, Chen C, et al.
J Formos Med Assoc
. 2025 Feb;
PMID: 39919992
Background/purpose: The risk of hepatocellular carcinoma (HCC) is increased in patients with chronic hepatitis C (CHC) and elevated alanine transaminase (ALT) levels. The association between HCC and ALT levels after...
3.
Lee S, Yang S, Tsai P, Huang C, Chen C, Hung C, et al.
Clin Mol Hepatol
. 2025 Feb;
PMID: 39905837
Background & Aims: The survival benefit of direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) infection in patients with hepatocellular carcinoma (HCC), particularly in BCLC stages B/C, remains largely...
4.
Wang S, Wang S, Huang C, Chang T, Chang T, Lo C, et al.
Kaohsiung J Med Sci
. 2025 Jan;
41(2):e12929.
PMID: 39829106
An 8-week regimen of glecaprevir/pibrentasvir is recommended for treatment-naïve patients with chronic hepatitis C (CHC). In alignment with the Taiwanese government's objective to eliminate hepatitis C by 2025, this study...
5.
Liao C, Chen P, Shih Y, Chang W, Hsieh T, Huang T
Prev Med Rep
. 2025 Jan;
49():102951.
PMID: 39807183
Objective: The noncompliance rate with routine or surveillance colonoscopies is high, and the underlying reasons remain unverified among Asian patients with inflammatory bowel disease (IBD). This study aimed to examine...
6.
Lu M, Huang T, Chen P, Chen H, Yang C, Lin J, et al.
Medicine (Baltimore)
. 2024 Dec;
103(50):e40921.
PMID: 39686487
Upper gastrointestinal angiodysplasia (UGIA) is a unique mucosal vascular lesion that causes acute or recurrent gastrointestinal bleeding. Despite the increasing incidence of UGIA, the risk factors for bleeding in this...
7.
Liu F, Wang C, Chen P, Shih Y, Lin H, Lin J, et al.
World J Clin Cases
. 2024 Dec;
12(34):6696-6704.
PMID: 39650821
Background: Small bowel tumors (SBTs) are a heterogeneous group of difficult-to-diagnose tumors that account for 2%-5% of all gastrointestinal tumors. Single-balloon enteroscopy greatly enhances the diagnosis and treatment of SBTs....
8.
Yeh C, Chen R, Wu T, Chang S, Hsieh T, Shih Y, et al.
Clin Epigenetics
. 2024 Nov;
16(1):174.
PMID: 39614377
Background: The progression of liver cancer is a complicated process that involves genetic and epigenetic changes. Paired box 6 (PAX6) is a critical transcription factor for embryonic development. PAX6 is...
9.
Huang H, Shiu T, Chan D, Chang C, Lin H, Lin J, et al.
Pancreatology
. 2024 Nov;
24(8):1294-1301.
PMID: 39500645
Background: Single nucleotide polymorphism (SNP) rs1347093 shows statistically significant association with lung cancer risk, but there is no further rs1347093 expression quantitative trait loci (eQTL) effect information. SNP rs1347093 is...
10.
Jang T, Huang C, Chang T, Yang C, Lo C, Hung C, et al.
J Formos Med Assoc
. 2024 Aug;
PMID: 39168745
Background/aims: Hepatitis C virus (HCV) eradication using antiviral agents augments the metabolic profile. Changes in glycated hemoglobin (HbA1c) levels in chronic hepatitis C patients who receive glecaprevir/pibrentasvir (GLE/PIB) remain elusive....